Skip to Main Content

Paper Details

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs.
Immunity
61
2021
B cell abnormalities, CD8, CD8+, CD8+ T cell, CD8+ T cells, CoV, S, S1, SARS, SARS-, SARS-CoV, SARS-CoV-2, Single, coronavirus 2, dysfunction in the lungs, immune pathology, inflammation, interferon-stimulated genes, lung cells, macaques, mice, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Sailaja GangadharaYerkes National Primate Research Center, Emory University, Emory School of Medicine
Venkata S BollimpelliYerkes National Primate Research Center, Emory University, Emory School of Medicine
Lilin LaiYerkes National Primate Research Center, Emory University, Emory University School of Medicine
Stephanie FischingerRagon Institute of MGH
David C MontefioriDuke University School of Medicine
Pei-Yong ShiThe University of Texas Medical Branch
Vineet D MenacheryThe University of Texas Medical Branch
Galit AlterRagon Institute of MGH
Steven E BosingerYerkes National Primate Research Center, Emory University, Emory School of Medicine
Mehul S SutharYerkes National Primate Research Center, Emory University, Emory University School of Medicine
Rama Rao AmaraYerkes National Primate Research Center, Emory University, Emory School of Medicine
  • 1 - 11

Datasets

Release 1.2